Kopran share news, announcements and annual reports
NSE: KOPRANBSE: 524280Pharmaceuticals & BiotechnologySmall Cap
Kopran Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1993 on BSE, Jun 1999 on NSE
Last close ₹239.05down ₹12.95 (5.14%)BSE ₹239.30
Share price at the NSE close on 30 Oct 2026. Previous close ₹252.00.
30 Oct: open ₹253.80, high ₹253.80, low ₹237.50
52-week range of traded prices to 30 Oct 2026
₹107.00Low, 30 Mar 2026₹295.83High, 30 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,155 Cr1,663rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 46.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.26%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.29
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,52,24248.4% delivered
Kopran share news and announcements
451 announcements, routine notices left out, newest first. Page 7 of 10.
Nov 2014
14 Nov · Meeting
Oct 2014
30 Oct · Meeting
29 Oct · Board meeting
To consider and approve Unaudited Financial Results for the Quarter ended September 30, 2014.
Sep 2014
29 Sep · Board meeting
29 Sep · Board meeting
To consider, subject to approval of shareholders by way Postal Ballot among other items: (1) To consider issue of Equity Shares and/ or Warrants on Preferential basis to Promoter Group. (2) To consider Slump Sales of Active Pharmaceutical Ingredients (API) business to its Subsidiary Company, Kopran Research Laboratories Limited.18 Sep · Meeting
Aug 2014
5 Aug · Board meeting
To consider and approve Unaudited Financial Results for the Quarter Ended June 30, 2014. Further, it is informed that, the Trading Window will be closed from August 07, 2014 to August 14, 2014 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company.
Jul 2014
25 Jul · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from September 08, 2014 to September 11, 2014 (both days inclusive) for the purpose of Annual General Meeting (AGM) to be held on September 11, 2014.
May 2014
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2014, has approved the following: 1. Resignation of Mr. Abhinav Mathur as a Company Secretary & Compliance Officer of the Company was accepted by the Board of Directors of the Company. 2. Appointment of Mr. Sunil Sodhani as a Company Secretary & Compliance Officer of the Company was approved by the Board of Directors of the Company.
Apr 2014
Mar 2014
Feb 2014
13 Feb · Results
4 Feb · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended December 31, 2013. Further, the Trading Window will be closed for a period of 7 days i.e. From February 07, 2014 to February 14, 2014 as per the code of Internet Procedure and Conduct for Prevention of Insider Trading adopted by the Company.
Nov 2013
15 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 13, 2013, has approved the following: Renewal of the appointment of Mr. Surendra Somani as Executive Vice Chairman of the Company for further period of 5 years w.e.f. January 01, 2014.13 Nov · Results
Oct 2013
28 Oct · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended September 30, 2013.
Sep 2013
Aug 2013
12 Aug · Management
Mr. V. N. Khanna, Independent Director of the Company was appointed as new Chairman of the Board of Directors.
Jul 2013
31 Jul · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended June 30, 2013.23 Jul · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from September 11, 2013 to September 14, 2013 (both days inclusive) for the purpose of Annual General Meeting (AGM) to be held on September 14, 2013.15 Jul · Updates
"Kopran Ltd. is lauching a new "SPARKLE" in the FMCG category. The first product which would be launched would be Toothpaste, followed by various other products.
May 2013
20 May · Board meeting
To consider and take on record Audited Financial Results for the Year ended March 31, 2013.
Apr 2013
Feb 2013
13 Feb · Management
Board of Directors of the Company at its meeting held on February 12, 2013 has approved the following: (1) Appointment of Mr. V. K. Bhandari as an Independent Director of the Company with effect from February 12, 2013. (2) Renewal of the appointment of Mr. Ajit Jain as Whole Time Director of the Company for further period of 3 years w.e.f February 01, 2013.1 Feb · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended December 31, 2012.
Nov 2012
Oct 2012
29 Oct · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended September 30, 2012.
Sep 2012